1,023 results on '"Mizuno, Ryuichi"'
Search Results
2. Appropriate definition of non-metastatic castration-resistant prostate cancer (nmCRPC) and optimal timing of androgen receptor signaling inhibitor (ARSI)
3. Risk factors for postoperative fever after laparoscopic adrenalectomy focusing on hormones produced: a case control study
4. Prediction of pathological up-staging after radical nephroureterectomy in patients with upper tract urothelial carcinoma
5. Anemia in patients ≥ 75 years with metastatic clear cell renal cell carcinoma: an important poor prognostic factor in the international metastatic renal cell carcinoma database consortium model
6. Applicability of the regression approach for histological multi-class grading in clear cell renal cell carcinoma
7. Prognostic impact of tumor ureteral invasion on recurrence after radical cystectomy
8. Profiling Fibroblast Growth Factor Receptor 3 Expression Based on the Immune Microenvironment in Upper Tract Urothelial Carcinoma
9. Comparing the efficacy of tadalafil and tamsulosin for managing erectile dysfunction and lower urinary tract symptoms in prostate brachytherapy patients: a prospective study
10. Long-Term Prognosis and Treatment Strategy of Persistent PSA After Radical Prostatectomy
11. Detection of the Highest-Grade Lesion in Multifocal Discordant Prostate Cancer by Multiparametric Magnetic Resonance Imaging
12. Factors affecting the selection of eligible candidates for focal therapy for prostate cancer
13. Prognostic role of the innate immune signature CD163 and “eat me” signal calreticulin in clear cell renal cell carcinoma
14. Strategy for PSA progression in patients undergoing salvage radiation for biochemical recurrence after radical prostatectomy
15. Impact of tumor contact surface area on collecting system entry in robot-assisted partial nephrectomy: a retrospective analysis
16. Prognostic value of PD-L1 expression in recurrent renal cell carcinoma after nephrectomy: a secondary analysis of the ARCHERY study
17. Current clinical perspective of urological oncology in the adolescent and young adult generation
18. Site-Specific Differences in PD-1 Blockade Success and Biomarkers in Urothelial Carcinoma Treated with Pembrolizumab
19. A low subcutaneous fat mass is a risk factor for the development of inguinal hernia after radical prostatectomy
20. Hybridisation chain reaction-based visualisation and screening for lncRNA profiles in clear-cell renal-cell carcinoma
21. Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
22. ASO Visual Abstract: Long-Term Prognosis and Treatment Strategy of Persistent PSA After Radical Prostatectomy
23. IDH2 stabilizes HIF‐1α‐induced metabolic reprogramming and promotes chemoresistance in urothelial cancer
24. Pembrolizumab plus axitinib versus sunitinib in metastatic renal cell carcinoma: outcomes of Japanese patients enrolled in the randomized, phase III, open-label KEYNOTE-426 study
25. Long-term complete response in small cell bladder carcinoma treated with carboplatin, etoposide, and atezolizumab
26. Optimal surgical treatment for paratesticular leiomyosarcoma: retrospective analysis of 217 reported cases
27. Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
28. Landscape of prognostic signatures and immunogenomics of the AXL/GAS6 axis in renal cell carcinoma
29. Effects of transurethral resection under general anesthesia on tumor recurrence in non-muscle invasive bladder cancer
30. Multiplexed single-cell pathology reveals the association of CD8 T-cell heterogeneity with prognostic outcomes in renal cell carcinoma
31. Evaluation of Gleason Grade Group 5 in a Contemporary Prostate Cancer Grading System and Literature Review
32. Role of Previous Malignancy History in Clinical Outcomes in Patients with Initially Diagnosed Non-Muscle Invasive Bladder Cancer
33. Negative impact of neoadjuvant hormonal therapy on detecting biochemical recurrence after radical prostatectomy
34. On-treatment C-reactive protein control could predict response to subsequent anti-PD-1 treatment in metastatic renal cell carcinoma
35. The first detailed annual record on the National Clinical Database Urology Division in Japan: A report on five surgical procedures.
36. Annual record on the number of general urological surgeries registered in the National Clinical Database system between April 2018 and December 2021 in Japan.
37. Radiologic features of mixed epithelial and stromal tumors of the kidney: Hyperattenuating on unenhanced computed tomography and T2-hypointensity on magnetic resonance imaging
38. The efficacy of the TachoSil binding suturing technique in laparoscopic partial nephrectomy to prevent the development of pseudoaneurysm
39. PD36-08 ARTIFICIAL INTELLIGENCE-BASED SURGICAL PHASE RECOGNITION IN ROBOT-ASSISTED RADICAL PROSTATECTOMY AND CROSS-SURGEON EXTERNAL VALIDITY VERIFICATION
40. PD20-09 THREE-DIMENSIONAL IMAGING AND SPATIAL ANALYSIS OF INTACT TISSUE IMPROVE DIAGNOSTIC YIELD AND ACCURACY IN UPPER TRACT UROTHELIAL CARCINOMA DIAGNOSIS
41. Malignancy-associated membranous nephropathy with PLA2R double-positive for glomeruli and carcinoma
42. Long-term follow-up comparing salvage radiation therapy and androgen-deprivation therapy for biochemical recurrence after radical prostatectomy
43. Can random bladder biopsies be eliminated after bacillus Calmette–Guérin therapy against carcinoma in situ?
44. Evaluating the Oncological Outcomes of Pure Laparoscopic Radical Nephroureterectomy Performed for Upper-Tract Urothelial Carcinoma Patients: A Multicenter Cohort Study Adjusted by Propensity Score Matching
45. Optimal treatment strategy for paratesticular liposarcoma: retrospective analysis of 265 reported cases
46. External validation of the "optimal PSA follow-up schedule after radical prostatectomy” in a new cohort
47. Type of patients in whom biochemical recurrence after radical prostatectomy can be observed without salvage therapy
48. TNFAIP2 expression induces epithelial-to-mesenchymal transition and confers platinum resistance in urothelial cancer cells
49. Cumulative incidence and risk factors for recurrence of upper tract urothelial carcinoma in patients undergoing radical cystectomy
50. Impact of prostatic shape on the difficulty of robot‐assisted laparoscopic radical prostatectomy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.